Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial
Titel:
Isatuximab, carfilzomib, lenalidomide, and dexamethasone in patients with newly diagnosed, transplantation-eligible multiple myeloma (SKylaRk): a single-arm, phase 2 trial
Auteur:
O'Donnell, Elizabeth Mo, Clifton Yee, Andrew J Nadeem, Omar Laubach, Jacob Rosenblatt, Jacalyn Munshi, Nikhil Midha, Shonali Cirstea, Diana Chrysafi, Pavlina Horick, Nora Richardson, Paul G Raje, Noopur